2010
DOI: 10.3892/etm_00000103
|View full text |Cite
|
Sign up to set email alerts
|

Sensitive quantitative assay for point mutations in the rat H-ras gene based on single nucleotide primer extension

Abstract: Abstract. point mutations in oncogenes and tumor suppressor genes occur at early stages in the carcinogenic process. point mutations in ras family oncogenes are the most common mutational events in several types of human cancer, and are available as molecular markers for the detection of cancer cells in carcinogenicity bioassay systems as well as in clinical samples. although several techniques are utilized to detect point mutations in carcinogenicity bioassay systems, the sensitivity is too low to determine a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 21 publications
1
4
0
Order By: Relevance
“…The values at days 10 and 17 were slightly higher than those of the control group. The control levels of the rat liver BrdU indices detected in the present study at each time point fell into the range of historical background values for data obtained in our laboratory 10 , 11 , 12 . At the start of the experiment on day 3, the BrdU index levels in young rats of both the control and ETBE-treated groups were much higher than those observed in rats at days 10, 17 and 28 ( Table 1 ).…”
Section: Resultssupporting
confidence: 63%
“…The values at days 10 and 17 were slightly higher than those of the control group. The control levels of the rat liver BrdU indices detected in the present study at each time point fell into the range of historical background values for data obtained in our laboratory 10 , 11 , 12 . At the start of the experiment on day 3, the BrdU index levels in young rats of both the control and ETBE-treated groups were much higher than those observed in rats at days 10, 17 and 28 ( Table 1 ).…”
Section: Resultssupporting
confidence: 63%
“…Rats exposed to this carcinogen were examined to determine the formation of 1) MeIQx-DNA adducts [105], 2) mutations at the H-ras locus [106] and in LacI transgenes [107], 3) pre-neoplastic lesions (PNL) in the form of GST-positive foci [105], and 4) hepatocellular adenomas and carcinomas [108]. These endpoints were evaluated at 4, 16, 16-32 and 56 weeks of repeat dosing, respectively.…”
Section: Appendix 1 Analysis Of the Relationships Among Pods For Carmentioning
confidence: 99%
“…After the 1-week application of MeIQx in the diet at wide range of doses, H-ras mutation frequency detected by TCEL assay in the rat livers of all groups receiving from 0.001 ppm to 100 ppm dose of MeIQx did not differ from the control value. On the other hand, in the livers of rats treated for 2 weeks, H-ras mutation frequency was elevated in dose-dependent manner, particularly in 10 ppm and 100 ppm MeIQx groups with statistical significance [19].…”
Section: Hepatocarcinogenicity and Mutagenicity Of 2-amino-38-dimethmentioning
confidence: 86%
“…Similarly, the mutation level of H-ras gene, which role in rat hepatocarcinogenesis is not clear, was significantly increased in the livers of rats administered MeIQx at doses higher than 1 ppm (Table 1) [19]. After the 1-week application of MeIQx in the diet at wide range of doses, H-ras mutation frequency detected by TCEL assay in the rat livers of all groups receiving from 0.001 ppm to 100 ppm dose of MeIQx did not differ from the control value.…”
Section: Hepatocarcinogenicity and Mutagenicity Of 2-amino-38-dimethmentioning
confidence: 97%